PACAP is hét platform voor lange termijn onderzoek

naar de behandeling en (patiënt gerapporteerde)
uitkomsten van alvleesklierkanker

48

deelnemende
centra

4346

patiënten in
PACAP PROMs

5998

patiënten in
PACAP cohort

There is often an overlap in both questionnaires and patient population in PACAP PROMs and other projects. By collaborating, we avoid that patients fill in questionnaires twice. PACAP collaborates with the following studies.

TIMEPAN

15 september 2022

Timing of start of systemIc treatment for asymptomatic MEtastasized PANcreatic cancer (TIMEPAN): a randomized controlled multicenter trial

Read more

RADAR-PANC

15 september 2022

Recurrent Disease Detection after Resection of Pancreatic Adenocarcinoma using a Standardized Surveillance Strategy (RADAR-PANC): a nationwide, randomized controlled trial

Read more

PREOPANC-3

15 september 2022

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer 

Read more

PANCOSAR

15 september 2022

Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients

Read more

ARCADE

15 september 2022

Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy 

Read more

DIPLOMA-2

15 september 2022

Minimally invasive versus open pancreatoduodenectomy for pancreatic and periampullary neoplasms

Read more

PREOPANC-4

15 september 2022

Nationwide implementation program for optimal multidisciplinary management and resection of locally advanced pancreatic cancer. 

Read more

DIPLOMA

15 maart 2021

Distal pancreatectomy, minimally invasive or open, for malignancy: a Pan-European randomized multicenter study

Read more

PANFIRE-III

18 maart 2021

Study investigating treatment with IRE (nanoknife) of the primary tumor whether or not in combination with immunotherapy in inoperable pancreatic patients with liver metastases

Read more

PEGASUS

14 maart 2021

Study investigating treatment with IRE (nanoknife) of the primary tumor whether or not in combination with immunotherapy in inoperable pancreatic patients with liver metastases

Read more

PREOPANC-2

13 maart 2021

Neoadjuvant FOLFIRINOX versus neoadjuvant chemoradiotherapy and adjuvant chemotherapy for (borderline) resectable pancreatic carcinoma

Read more

eQuiPe

12 maart 2021

How do patients with advanced cancer and their loved ones experience quality of life and quality of care

Read more